Abatacept therapy offers promising results treating juvenile dermatomyositis
![Abatacept therapy offers promising results treating juvenile dermatomyositis](https://crohnsfighters.com/wp-content/uploads/2023/02/scidaily-logo-rss.png)
Juvenile dermatomyositis, a rare but often severe and chronic systemic autoimmune disease, includes a large number of patients who are treatment resistant, requiring long term immunosuppressive therapy. A small study shows promise using a targeted biologic therapy called abatacept to treat such patients.